‘March-in’ rights: Why Biden’s changes contradict the point of the Bayh-Dole Act

The unintended consequences of President Biden’s proposal to dictate prices would destroy the US’ thriving tech transfer framework—and in industries far beyond pharmaceuticals, explain former USPTO directors Andrei Iancu and David Kappos.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

The Biden administration’s trade policy: what will it mean for IP?

14 December 2020 The incoming US presidential administration has made it clear that it will prioritise trade policy and undo a number of Trump’s decisions in this area, which could lead to significant ramifications for IP. Michael Nesheiwat and Jess Collen of law firm Collen IP report.

IP under Biden: what does the future look like?

10 November 2020 US President-elect Joe Biden is pushing forward with his plans for office, but what effect will his presidency have on IP?